Author

C. Degos

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

D. Olive· 2 shared L. Gorvel· 2 shared A. Ben Amara· 1 shared A. Zarubica· 1 shared A.-S. Chretien· 1 shared B. Malissen· 1 shared C. Demerle· 1 shared E. Billon· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. Olive

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tertiary lymphoid structures are associated with enhanced macrophage activation, immune checkpoint expression and predict outcome in cervical cancer.

L. Gorvel, M. Panouillot, M.-S. Rouviere, E. Billon, S. Fattori, J. Sonongbua, N. Boucherit, A. Ben Amara, O. Quilichini, S. GRANJEAUD, C. Degos, X. Carcopino, E. Lambaudie, A.-S. Chretien, R. Sabatier, , D. Olive

This study shows that tertiary lymphoid structures in cervical cancer are linked to immune activation and better patient outcomes.

bioRxiv · Aug 17, 2023Immunology

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors

C. Demerle, L. Gorvel, M. Mello, S. Pastor, C. Degos, A. Zarubica, F. Angelis, F. FIORE, J. Nunes, B. Malissen, L. Greillier, G. Guittard, H. Luche, F. Barlesi, D. Olive

bioRxiv · Nov 4, 2022 · PreprintImmunology